Key Takeaways
- • Garner Health closed a $100 million Series E funding round led by Index Ventures, valuing the care navigation startup at $2.74 billion, just three months after securing $118 million in Series D funding at a $1.35 billion valuation.
- • The round included participation from prominent venture investors Kleiner Perkins, Redpoint, Thrive, Sequoia, and Founders Fund, alongside Kaiser Permanente Ventures, signaling strong institutional confidence in the healthcare AI and quality measurement sector.
- • Garner Health operates a platform analyzing over 60 billion deidentified medical records from 320 million patients to identify high-quality, cost-effective providers and create financial incentives for patients to seek care from top performers.
- • The company currently serves nearly 800 organizations representing 2.5 million members, with clients reporting an average 12% annual reduction in healthcare spending, and maintains partnerships with major healthcare systems including Mercy, Atlantic Health, Teladoc Health, and Marathon Health.
- • Capital will be deployed to expand the provider quality platform, accelerate AI-powered product innovation, and broaden market access as Garner addresses the structural misalignment in U.S. healthcare reimbursement models.
Summary
Garner Health, a digital care navigation platform founded in 2019, has secured $100 million in Series E funding at a $2.74 billion valuation, advancing its mission to align financial incentives with healthcare quality outcomes. Index Ventures led the round, with co-investment from marquee venture firms including Kleiner Perkins, Redpoint, Thrive, Sequoia, and Founders Fund, plus Kaiser Permanente Ventures. The funding represents a doubling of the company's valuation in three months, following a $118 million Series D raise completed in February 2026 that valued the firm at $1.35 billion.
The startup's core thesis addresses a fundamental market failure in U.S. healthcare: the fee-for-service model that compensates providers for volume rather than outcomes. Garner leverages an expansive dataset comprising over 60 billion deidentified medical records from 320 million patients to systematically measure physician quality and cost-effectiveness. The platform identifies providers who adhere to evidence-based practice, minimize unnecessary procedures, and demonstrate superior patient health outcomes relative to peers. By making physician quality measurable and transparent, Garner creates a market mechanism where employers, hospitals, and patients can identify and preferentially route care to high-performing providers.
Index Ventures partner Jahanvi Sardana emphasized the significance of this application, stating that Garner is "using AI to make physician quality measurable for the first time" and has "built the market mechanism healthcare always needed." This characterization reflects venture investors' conviction that Garner's approach represents one of the most impactful healthcare AI implementations available.
Operationally, Garner has achieved meaningful traction, serving nearly 800 organizations and reaching 2.5 million members. Clients report 12% annual reductions in healthcare spending, a metric that directly translates to employer savings and improved care efficiency. The company has secured partnerships with major integrated delivery networks and telehealth providers, including Mercy, Atlantic Health, Teladoc Health, and Marathon Health, establishing credibility within the healthcare establishment.
The capital infusion will fund expansion of its provider quality platform, scale AI-driven product development, and extend market penetration. As healthcare systems face sustained pressure to reduce costs while maintaining quality, Garner's ability to quantify and incentivize better outcomes positions it as a critical infrastructure layer in the employer-sponsored health benefits ecosystem.
The startup's core thesis addresses a fundamental market failure in U.S. healthcare: the fee-for-service model that compensates providers for volume rather than outcomes. Garner leverages an expansive dataset comprising over 60 billion deidentified medical records from 320 million patients to systematically measure physician quality and cost-effectiveness. The platform identifies providers who adhere to evidence-based practice, minimize unnecessary procedures, and demonstrate superior patient health outcomes relative to peers. By making physician quality measurable and transparent, Garner creates a market mechanism where employers, hospitals, and patients can identify and preferentially route care to high-performing providers.
Index Ventures partner Jahanvi Sardana emphasized the significance of this application, stating that Garner is "using AI to make physician quality measurable for the first time" and has "built the market mechanism healthcare always needed." This characterization reflects venture investors' conviction that Garner's approach represents one of the most impactful healthcare AI implementations available.
Operationally, Garner has achieved meaningful traction, serving nearly 800 organizations and reaching 2.5 million members. Clients report 12% annual reductions in healthcare spending, a metric that directly translates to employer savings and improved care efficiency. The company has secured partnerships with major integrated delivery networks and telehealth providers, including Mercy, Atlantic Health, Teladoc Health, and Marathon Health, establishing credibility within the healthcare establishment.
The capital infusion will fund expansion of its provider quality platform, scale AI-driven product development, and extend market penetration. As healthcare systems face sustained pressure to reduce costs while maintaining quality, Garner's ability to quantify and incentivize better outcomes positions it as a critical infrastructure layer in the employer-sponsored health benefits ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.